Skip to main content

Table 1 Patient characteristics

From: Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease

 

Controls (n = 44)

MVP (all) (n = 80)

MVP (No significant MR) (n = 34)

“Borderline” (n = 13)

Age (y)

46 [38–57]

52 [40–63]*

50 [35–59]

51 [36–63]

Male

23 (52%)

37 (46%)

14 (41%)

7 (50%)

BSA (m2)

1.9 [1.7–2.1]

1.7 [1.6–2.0]*

1.7 [1.6–2.0]*

1.8 [1.6–1.9]*

Hypertension

18/42 (43%)

27/73 (37%)

10/31 (32%)

1/9 (11%)

Diabetes mellitus

5/42 (12%)

0/51 (0%)

0/23 (0%)

1/13 (13%)

Current or former smoker

13/42 (31%)

13/50 (26%)

6/23 (26%)

0/9 (0%)*

Dyslipidemia

12/42 (29%)

16/52 (31%)

7/23 (30%)

2/9 (22%)

Obesity

10/42 (23%)

6/80 (8%)**

3/34 (9%)*

0/13 (0%)*

Family history of MVP (%)

0/41 (0%)

5/73 (7%)

2/31 (6%)

0/9 (0%)

Dyspnea

12/41 (29%)

19/71 (27%)

7/31 (23%)

2/8 (25%)

Chest pain

9/41 (22%)

17/72 (24%)

7/32 (22%)

1/8 (13%)

Palpitations

17/41 (41%)

50/98 (51%)

18/31 (58%)

4/8 (50%)

Sinus rhythm

44/44 (100%)

78/78 (100%)

34/34 (100%)

13/13 (100%)

  1. BSA body surface area. MR mitral regurgitation. MVP mitral valve prolapse
  2. Values expressed as n (%) or medians [interquartile range]. *P Value < 0.05 versus controls. **P Value < 0.01 versus controls